0.8802
-0.0402
(-4.37%)
At close: April 17 at 8:01:18 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-20,440
-20,440
-174,884
-241,124
-37,432
Investing Cash Flow
230,321
230,321
144,640
-166,850
-138,410
Financing Cash Flow
-186,974
-186,974
69,600
54,326
51,879
End Cash Position
126,250
126,250
103,343
63,987
417,635
Income Tax Paid Supplemental Data
--
--
--
40
1,221
Interest Paid Supplemental Data
25,376
25,376
37,857
34,878
18,684
Capital Expenditure
--
--
-286
-2,039
-1,289
Issuance of Capital Stock
1,455
1,455
71,718
6,358
40,903
Issuance of Debt
36,979
36,979
--
240,679
--
Repayment of Debt
-260,387
-260,387
--
-190,750
--
Free Cash Flow
-20,440
-20,440
-174,884
-241,124
-38,721
12/31/2021 - 11/22/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CXF.F Chimerix, Inc.
7.48
+0.27%
4AJ0.BE Alk-Abello A/S
19.68
+2.23%
4QK.F Codexis, Inc.
1.8460
+0.65%
IPIX Innovation Pharmaceuticals Inc.
0.0002
0.00%
NEUP Neuphoria Therapeutics Inc.
5.14
+0.38%
TSVT 2seventy bio, Inc.
4.9800
+0.20%
AEON AEON Biopharma, Inc.
0.4050
+1.28%
CMRX Chimerix, Inc.
8.54
-0.12%
ATOS Atossa Therapeutics, Inc.
0.6231
+2.99%